
Neurodegenerative disorders are being fought with €28m
The Danish biotech Teitur Trophics ApS, aiming to treat chronic neurological disorders, has completed a €28m Series A funding. With the money, Teitur...

500 experts at the 7th AMR Conference in Basel
That antimicrobial resistance can no longer be considered a silent pandemic became abundantly clear at the AMR Conference in Basel from March 16-17....

EU to decarbonise aviation sector through green fuel targets
So far, SAF have been produced in tiny quantities and are far more expensive than kerosene.According to European Commissions draft regulation, fuel...

Adaptyv Biosytems launches protein engineering foundry
Machine learning algorithms and generative AI are upending traditional processes in life sciences and collapsing time frames in drug discovery and...

Wacker AG expands biotech business through €100m acquisition
Following Wacker’s purchase of fermentation assets in the northern Spanish city of León in 2016, the chemical group now owns the entire site. The...

Tay Therapeutics in licensing deal with VYNE Therapeutics
Tay Therapeutics Ltd’s exclusive license deal with VYNE Therapeutics Inc. on the oral BET inhibitor, TAY-B2 (now known as VYN201) forsees an upfront...

Nomi Biotech presents natural additive to preserve probiotics
Nomi Biotech sp zoo has presented a water-soluble formulation of curcumin with improved bioavailability in Frontiers in Nutrition allowing to...